
About Insightec
Insightec is a Healthcare company based in Tirat Carmel (Israel) founded in 1999 by Oded Tamir and Kobi Vortman. MR-interfaced ultrasound devices for cancer and neurology treatments are provided. Insightec has raised $574.2 million across 13 funding rounds from investors including GE Healthcare, Fidelity Investments and Baillie Gifford. The company has 541 employees. Insightec was last valued at $375 million in June 2024. Its chief executive, as recorded, is Kobi Vortman. Its website insightec.com draws about 34 thousand monthly visits. Insightec offers products and services including Exablate Neuro. Its focus areas include Life Sciences, Oncology, Medical Devices and Therapies. Its legal entity is Insightec Ltd.
Company details
Insightec was founded in 1999 in Tirat Carmel, Israel, as a provider of medical devices utilizing MR-interfaced ultrasound technology. The Exablate Neuro platform is employed to deliver focused sound waves guided by MRI for treating medication-refractory essential tremor, Parkinsons disease, uterine fibroids, and pain from metastatic bone tumors. Operations center on neurology and oncology sectors, with devices integrated into clinical settings for non-invasive procedures.
- Headquarters Tirat Carmel, Israel
- Employees 541
- Founders Oded Tamir, Kobi Vortman
- Stage Unicorn
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website insightec.com
- Social LinkedIn X Facebook YouTube
- Legal Name Insightec Ltd
- Total Equity Funding$574.2M (USD)
in 13 rounds
- Latest Funding Round$150M (USD), Series G
Jun 2024
- InvestorsGE Healthcare
& 26 more
- Employee Count541
Products & Services of Insightec
Insightec offers a comprehensive portfolio of products and services, including Exablate Neuro.
Platform for non-invasive treatment of Essential Tremor and Parkinson's Disease.
Apps and channels of Insightec
its YouTube channel INSIGHTEC has 3.3K subscribers and 30 videos.
Videos from Insightec
The most watched videos on Insightec's YouTube channel, INSIGHTEC (3.3K subscribers). Click a video to play it here.
More on INSIGHTEC.
Funding Insights of Insightec
Insightec has successfully raised a total of $574.2M across 13 strategic funding rounds. The most recent funding activity was a Series G round of $150 million completed in June 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $574.2M
- Total Rounds 13
- Last Round Series G β $150M
- First Round $15M
(Aug 2006)
- Investors Count 27
Latest 10 of 13 funding rounds of Insightec with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2024 | $150M | Series G | β | Fidelity Investments, Nexus NeuroTech Ventures | |
| Sep 2022 | Debt – Conventional | β | β | ||
| Nov 2020 | Series F | β | England | β | |
| Mar 2020 | $150M | Series F | $1.3B | Koch Disruptive Technologies | β |
| Dec 2017 | $150M | Series E | β | Koch Disruptive Technologies | |
| Dec 2015 | $22M | Series D | β | β | β |
| Sep 2014 | $12.5M | Series D | β | York Capital Management, GEOC | β |
| Jun 2014 | Series D | β | York Capital Management | ||
| Dec 2012 | $30.9M | Series C | β | GE Healthcare | β |
| Feb 2012 | $13.8M | Series B | β | GE Healthcare | β |
| Date | Valuation | Stage |
|---|---|---|
| Mar 2020 | $1.3B | β’β’β’β’β’β’β’β’ |
Full valuation and stage history of Insightec
Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.
- All valuation points
- Stage changes
- Dates
- Exports
Verified entity values are shown only after access is granted.
Last known valuation $375M (Jun 2024). 27 investors in total: 27 institutional.
Investors in Insightec
Insightec has secured backing from 27 investors, including institutional and venture fund investors. Prominent investors backing the company include GE Healthcare, Fidelity Investments and Baillie Gifford.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investments are focused on neurotechnology for brain disorders. | 2023 | nexusneurotech.com | San Francisco, United States | |
Private equity and hedge fund investments in healthcare are managed. | ally-bridge.com | Hong Kong, China | ||
Venture capital is provided to biomedical technology startups. | cataliocapital.com | New York, United States | ||
Global private equity investments are managed from Houston. | sarofim.com | Houston, United States | ||
Health-tech companies are targeted for venture capital investments. | 1999 | perceptivelife.com | New York, United States | |
| thecommunity.vc | ||||
Multiple sectors are invested in by the venture capital firm. | 2017 | kochdisruptivetechnologies.com | Wichita, United States | |
Exigent Capital is engaged in diversified financial services. | exigent.capital | Jerusalem, Israel | ||
| gocapitalgp.com | ||||
Venture capital investment fund | geequity.com | New York, United States |
Investor details for Insightec
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Insightec
152 people are tracked at Insightec (60 in leadership, 7 in board & advisors, 85 in team); the tracked headcount is 541.
| Name | Role | Group |
|---|---|---|
Oded Tamir | Co-Founder & COO | Leadership |
Kobi Vortman | Co-Founder & CEO | Leadership |
Maurice R. Ferre | Chairman & CEO | Leadership |
Maurice R. Ferré | CEO & Chairman | Leadership |
Augusto Grinspan | Chief Medical Officer | Leadership |
Arjun Desai | Chief Strategic Innovation Officer | Leadership |
Patrick Clingan | CFO | Leadership |
Ivan Delevic | Global Head of Strategic Marketing, Upstream & Business Development | Leadership |
Jake Ghannam | Chief Commercial Officer (cco) | Leadership |
Baruch Avruch | Deputy General Manager | Leadership |
J. Michael Quijano | Director, Key Accounts U.s. & Latam Regions | Leadership |
Greg Davault | Vp, Global Marketing | Leadership |
Amy Rosenbaum Charley | Chief Legal Officer | Leadership |
Merav Bar | HR Business Partner | Leadership |
Gilat Schiff | Director, Clinical Safety | Leadership |
Eyal Zadicario | COO & General Manager | Leadership |
Joel Norton | VP, Human Resources | Leadership |
Adi Greenberg | Chief Technology Officer | Leadership |
Amy Blaha | Director Sales Operations | Leadership |
Liron Ketrariu | Director Of BRM & Digital Applications | Leadership |
132 more people are available in the full profile.
Complete people profiles for Insightec
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Insightec
4 dated milestones of Insightec across 25 years, from founding to its latest funding, stage changes and deals.
- Founded Insightec is founded.
- Funding First funding round of $15.0M.
- Milestone Reaches Unicorn status.
- Funding Latest funding round, Series G, of $150.0M.
Web traffic of Insightec
The website of Insightec (insightec.com) receives about 34K visits a month.
- Monthly visits34K
▲ 3.3% vs previous month
Websites whose visitors overlap most with Insightec. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
fusfoundation.org | fusfoundation.org | 100% | #593,619 | β | |
uterine-fibroids.org | uterine-fibroids.org | 92% | β | ||
| medtronic.com | 90% | 2.6M | #22,622 | View details | |
fibroidrelief.org | fibroidrelief.org | 76% | β | ||
adenomyosis.org | adenomyosis.org | 72% | β | ||
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 35 similar websites and full traffic analytics for Insightec
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 35 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Insightec
Complete news archive for Insightec
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Insightec
Insightec was founded in 1999 and raised its 1st funding round 7 years after it was founded.
Insightec is headquartered in Tirat Carmel, Israel. It is registered at Tirat Carmel, Haifa District, Israel.
Kobi Vortman is the CEO of Insightec, as recorded in our data. They have also founded this company.
Insightec is a funded company, having raised a total of $574.2M across 13 funding rounds to date. The company's 1st funding round was a Series B of $13.8M, raised on Aug 2006.
Insightec has 541 employees.
Insightec was founded in 1999 in Tirat Carmel, Israel, as a provider of medical devices utilizing MR-interfaced ultrasound technology. The Exablate Neuro platform is employed to deliver focused sound waves guided by MRI for treating medication-refractory essential tremor, Parkinsons disease, uterine fibroids, and pain from metastatic bone tumors. Operations center on neurology and oncology sectors, with devices integrated into clinical settings for non-invasive procedures.
Insightec offers Exablate Neuro.
Insightec has 27 investors. Key investors include GE Healthcare, Fidelity Investments, Baillie Gifford, Perceptive Advisors, and Koch Disruptive Technologies.
The valuation of Insightec is $375M as of Jun 2024.
Insightec operates through Insightec Ltd.
